[1]
I. C. M. Mendes, R. F. Mamani, D. R. A. Coelho, and C. Pimentel, “Myelotoxicity and kidney dysfunction related to the use of trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia: a case report of severe adverse events with a common drug”, Rev. Inst. Med. Trop. São Paulo, vol. 66, p. e18, Mar. 2024, doi: 10.1590/.